Država: Avstralija
Jezik: angleščina
Source: Department of Health (Therapeutic Goods Administration)
Gallium(67Ga) citrate
Lantheus MI Australia Pty Ltd
Medicine Registered
GALLIUM CITRATE GA 67 INJECTION, USP Gallium Citrate Ga 67 CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions about Gallium Citrate Ga 67. It does not contain all of the available information about Gallium Citrate Ga 67. It does not replace talking to your doctor. All medicines have risks and benefits. Your doctor has weighed the risks of you receiving Gallium Citrate Ga 67 against the benefits he or she expects it will have. IF YOU HAVE ANY CONCERNS ABOUT HAVING THIS MEDICINE, ASK YOUR DOCTOR. KEEP THIS LEAFLET. You may need to read it again. WHAT IS GALLIUM CITRATE GA 67 Gallium Citrate ga67 Injection contains an isotope of the element Gallium and belongs to a group of medicines called radiopharmaceutical agents, which are all radioactive. WHAT GALLIUM CITRATE GA 67 IS USED FOR Gallium Citrate Ga 67 is used to demonstrate the presence of following malignancies: Hodgkins disease, lymphomas and bronchogenic carcinoma. Positive Ga 67 uptake in the absence of prior symptoms warrants follow-up as an indication of a potential disease state. Your doctor may have prescribed Gallium Citrate Ga 67 for another purpose. Ask your doctor if you have any questions about why Gallium Citrate Ga 67 has been prescribed for you. If you have any concerns, you should discuss these with your doctor. This medicine is only available with a doctor’s prescription. BEFORE YOU ARE GIVEN GALLIUM CITRATE GA 67 Before you are given Gallium Citrate Ga 67 your doctor will explain to you the procedure you are about to undergo, and the radioactive medicine you will be given. You must discuss any concerns you have with your doctor. Gallium Citrate Ga 67 is not recommended for patients less than 18 years of age. If you Preberite celoten dokument
515286-0411 April 2011 GALLIUM CITRATE GA 67 INJECTION, U.S.P. AUSTRALIA FOR DIAGNOSTIC USE DESCRIPTION: Gallium Citrate Ga 67 Injection, U.S.P. is supplied in isotonic solution as a sterile, non-pyrogenic diagnostic radiopharmaceutical for intravenous administration. Each milliliter of the isotonic solution contains 74 MBq of Gallium Ga 67 on the calibration date, as a complex formed from 9ng Gallium Chloride Ga 67, 2 mg of sodium citrate, 6.8mg sodium chloride, and 0.9% benzyl alcohol w/v added as preservative. The pH is adjusted to between 4.5-8 with hydrochloric acid and/or sodium hydroxide solution. Gallium Ga 67, with a half-life of 78 hours, is cyclotron produced by the proton irradiation of enriched zinc oxide, is essentially carrier-free and contains negligible concentrations of other radioactive isotopes. PHYSICAL CHARACTERISTICS Gallium Ga 67 decays to stable Zinc Zn 67 by electron capture with a physical half-life of 78 hours. TABLE 1. PRINCIPAL RADIATION EMISSION DATA Radiation Mean % Disintegration Mean Energy (keV) Gamma-2 38.3 93.3 Gamma-3 20.9 184.6 Gamma-5 16.8 300.2 Gamma-6 4.7 393.5 TABLE 2. GALLIUM GA 67 DECAY CHART HALF-LIFE 78 HOURS Fraction Fraction Fraction Hours Remaining Hours Remaining Hours Remaining -48 1.53 30 0.77 90 0.45 -36 1.38 36 0.73 96 0.43 -24 1.24 42 0.69 108 0.38 -12 1.11 48 0.65 120 0.35 -6 1.05 54 0.62 132 0.31 0* 1.00 60 0.59 144 0.28 6 0.95 66 0.56 156 0.25 12 0.90 72 0.53 168 0.23 515286-0411 April 2011 18 Preberite celoten dokument